Scarica l'app Stockscreener
30.98
8.71%
-2.955
Pre-mercato:
30.49
-0.495
-1.60%
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM ExitWhat's Changed - Yahoo Finance
Goldman Sachs initiates MBX Biosciences stock with Sell rating on platform concerns - Investing.com Nigeria
Goldman Sachs initiates MBX Biosciences stock with Sell rating on platform concerns By Investing.com - Investing.com South Africa
Goldman Sachs Initiates Coverage on MBX with Sell Rating | MBX S - GuruFocus
Goldman Sachs Initiates Coverage on MBX Biosciences With Sell Rating, $18 Price Target - marketscreener.com
MBX Biosciences initiated with a Sell at Goldman Sachs - TipRanks
Is MBX Biosciences Inc. stock attractive for growth ETFsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser
MBX Biosciences drops 4% in premarket trading after Goldman initiates with sell - MSN
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones - Yahoo Finance
Sio Capital Management LLC Acquires New Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
How MBX Biosciences Inc. stock benefits from global expansionGold Moves & Growth Focused Stock Pick Reports - Newser
MBX Biosciences (MBX) Stock Analysis Report | Financials & Insights - Benzinga
MBX Biosciences (NASDAQ:MBX) Sets New 12-Month HighHere's What Happened - MarketBeat
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus - MSN
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% - Finviz
MBX Biosciences, Inc. $MBX Shares Purchased by Franklin Resources Inc. - MarketBeat
Rockefeller Capital Management L.P. Acquires Shares of 34,135 MBX Biosciences, Inc. $MBX - MarketBeat
MBX Biosciences (NASDAQ:MBX) Trading Up 5.6%Should You Buy? - MarketBeat
MBX S-8 & SEC Filings - Yahoo Finance Australia
MBX Biosciences Advances Phase 2a Study on PBH Treatment with Imapextide - MSN
Mbx biosciences stock reaches all-time high at 32.16 USD - Investing.com
Mbx biosciences stock reaches all-time high at 32.16 USD By Investing.com - Investing.com Australia
MBX: Once-monthly obesity candidate MBX 4291 shows strong potential for best-in-class tolerability and efficacy - TradingView
Will MBX Biosciences Inc. stock outperform tech sector in 2025Earnings Miss & Low Risk High Reward Ideas - newser.com
Is MBX Biosciences Inc. stock a safe buy before earningsSell Signal & Precise Swing Trade Entry Alerts - newser.com
Will MBX Biosciences Inc. stock rally after Fed decisionsTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MBX Biosciences stock maintains Buy rating at Jefferies on strong Phase 2 data By Investing.com - Investing.com South Africa
MBX Biosciences stock maintains Buy rating at Jefferies on strong Phase 2 data - Investing.com Nigeria
Can MBX Biosciences Inc. stock resist sector downturns - newser.com
Will MBX Biosciences Inc. stock remain a Wall Street favorite2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
MBX: Strong clinical progress and funding position drive multiple catalysts in endocrine and metabolic pipeline - TradingView
MBX: Strong clinical progress and funding drive late-stage catalysts in endocrine and metabolic programs - TradingView
How rising interest rates impact MBX Biosciences Inc. stockQuarterly Performance Summary & Precise Entry and Exit Recommendations - newser.com
Chart based exit strategy for MBX Biosciences Inc.Recession Risk & Smart Swing Trading Techniques - newser.com
Visualizing MBX Biosciences Inc. stock with heatmapsQuarterly Growth Report & Consistent Profit Trading Strategies - newser.com
What machine learning models say about MBX Biosciences Inc.Earnings Trend Report & Growth Focused Stock Reports - newser.com
Using flow based indicators on MBX Biosciences Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):